ACIU
AC Immune SA

3,757
Loading...
Loading...
News
all
press releases
New Strong Sell Stocks for August 6th
ACIU, ABEV and ALX have been added to the Zacks Rank #5 (Strong Sell) List on August 6, 2025.
Zacks·1mo ago
News Placeholder
More News
News Placeholder
AC Immune (ACIU) Reports Q2 Loss, Misses Revenue Estimates
AC Immune (ACIU) delivered earnings and revenue surprises of -25.00% and -57.30%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Zacks·1mo ago
News Placeholder
Royalty Pharma (RPRX) Earnings Expected to Grow: Should You Buy?
Royalty Pharma (RPRX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
AC Immune (ACIU) May Report Negative Earnings: Know the Trend Ahead of Q2 Release
AC Immune (ACIU) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·2mo ago
News Placeholder
AC Immune's Active Immunotherapy Shows Antibody Responses In Early Parkinson's Patients
AC Immune reports interim results from Phase 2 trial of ACI-7104.056 active immunotherapy for early Parkinson's disease. read more...
Benzinga·10mo ago
News Placeholder
Gold Down Over 1%; AC Immune Shares Spike Higher
read more...
Benzinga·1y ago
News Placeholder
Why Is Small-Cap Alzheimer's-Focused AC Immune Stock Trading Higher On Monday?
Unlocking hope for Alzheimer's with ACI-24.060. Takeda's agreement with AC Immune targets toxic forms of Abeta, potentially slowing disease progression. read more...
Benzinga·1y ago
News Placeholder
AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimers Disease
Takeda (TSE:4502/NYSE:TAK) and AC Immune SA (NASDAQ: ACIU) today announced an exclusive, worldwide option and license agreement for AC Immunes active immunotherapies targeting toxic forms of amyloid...
Business Wire·1y ago
News Placeholder
Futures Gain With All Time Highs In Sight As Key CPI Report Looms
Futures Gain With All Time Highs In Sight As Key CPI Report Looms US equity futures extended last week's solid gains when they traded just about 1% below all time highs, as investors...
Zero Hedge·1y ago
News Placeholder
AC Immune SA (ACIU, $3.46) Stochastic Oscillator left the oversold zone on March 18, 2024
This is a signal that ACIU's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Tickeron - Stocks·2y ago

Latest ACIU News

View

Advertisement. Remove ads.

Advertisement. Remove ads.